GRIN2D and Alzheimer disease: Taken together, these findings suggest that NR2D may play roles in various neuropsychiatric diseases, including glaucoma, Alzheimer’s disease, and schizophrenia, and may be a target for the development of novel drugs for the treatment of these neuropsychiatric diseases.